Vitreo Retinal Pre-filled Silicone Oil Syringe Market Outlook 2031
The Global vitreo retinal pre-filled silicone oil syringe market size was valued at USD 49.16 million in 2022 and is expected to reach USD 85.27 million by 2031, expanding at a CAGR of 6.31% during the forecast period, 2023–2031. The growth of the market is attributed to the increasing prevalence of retinal diseases, advancements in surgical techniques, growing geriatric population, rising awareness & easy access to healthcare facilities, and favorable reimbursement policies.
Rising awareness and easy access to healthcare facilities are driving the vitreo retinal pre-filled silicone oil syringe market. Improved healthcare infrastructure and increased awareness about retinal disorders have led to early diagnosis and treatment. This has created a high demand for vitreo retinal surgeries, thereby boosting the market. For instance,
In October 2023, a published report stated that approximately 258 million individuals worldwide suffer from mild vision impairment, while 295 million have moderate vision impairment, and 43 million are blind.
Favorable reimbursement policies are expected to propel the market. Reimbursement policies and insurance coverage for vitreo retinal surgeries have improved in many countries. This has made these procedures affordable and accessible, driving the demand for pre-filled silicone oil syringes.
The research report finds that the COVID-19 pandemic had a negative impact on the vitreo retinal pre-filled silicone oil syringe market. During the pandemic, many healthcare systems faced significant disruptions, with a high focus on managing COVID-19 cases. It postponed the vitreo retinal surgeries and other non-emergency surgeries. This led to a decline in the demand for pre-filled silicone oil syringes.
The global supply chain for medical devices experienced disruptions, due to lockdowns, travel restrictions, and manufacturing limitations. These challenges affected the production and distribution of pre-filled silicone oil syringes, leading to potential shortages and delays in availability.
Artificial Intelligence (AI) Impact on Vitreo Retinal Pre-filled Silicone Oil Syringe Market
Artificial intelligence (AI) is expected to have a positive impact on the vitreo retinal pre-filled silicone oil syringe market. AI assists in improved surgical planning by analyzing patient data and identifying potential complications. This helps surgeons to make informed decisions and reduce the risk of errors during surgery.
It assists in the development of precise and accurate pre-filled silicone oil syringes by analyzing data on surgical outcomes and identifying areas for improvement. This led to the development of effective and efficient syringes.
Vitreo Retinal Pre-filled Silicone Oil Syringe Market Dynamics
Increasing prevalence of retinal diseases is driving the vitreo retinal pre-filled silicone oil syringe market. The rising incidence of retinal diseases, such as retinal detachment and diabetic retinopathy, is fueling the demand for vitreo retinal surgeries and subsequently driving the market.
A published report in October 2023, revealed that approximately 9.6 million individuals in the US had undergone diabetic retinopathy treatment, with 1.8 million of these cases being classified as vision-threatening.
Advancements in surgical techniques are expected to boost the market. Technological advancements in vitreo retinal surgical techniques, such as small-gauge vitrectomy, have increased the adoption of pre-filled silicone oil syringes. These syringes offer convenience & accuracy, and reduce the risk of contamination during surgery.
Growing geriatric population is anticipated to propel the market. The prevalence of age-related eye disorders is increasing, due to the aging population. This demographic shift is expected to drive the demand for vitreo retinal surgeries and contribute to the growth of the pre-filled silicone oil syringe market.
High cost of pre-filled silicone oil syringes is expected to hamper the market. The cost of pre-filled silicone oil syringes is relatively high, which is expected to limit their affordability for some patients or healthcare facilities. This cost constraint affects the adoption of these syringes. Moreover, medical devices, including pre-filled silicone oil syringes, are subject to stringent regulations and approvals. Meeting these regulatory requirements is time-consuming and costly, posing a challenge for manufacturers and potentially limiting market entry.
Technological advancements in surgical techniques and materials used in vitreo retinal surgeries are expected to create lucrative opportunities for the development of improved pre-filled silicone oil syringes in the market. Innovations in syringe design, needle technology, and silicone oil formulations enhance the safety, accuracy, and ease of use of these syringes.
Growing demand for minimally invasive surgeries is expected to create opportunities in the market. The trend of minimally invasive surgical procedures in the field of ophthalmology is growing. Pre-filled silicone oil syringes offer a convenient and minimally invasive approach for vitreo retinal surgeries, which aligns with the increasing patient preference for such procedures.
Scope of The Vitreo Retinal Pre-filled Silicone Oil Syringe Market Report
The report on the global vitreo retinal prefilled silicone oil syringe market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Vitreo Retinal Pre-filled Silicone Oil Syringe Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Type (1000 CST, 2000 CST, Others), and Application (Clinics, Hospitals, Others)
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast
Key Players Covered in the Report
Alcon, Inc.; Bausch & Lomb, Inc.; Carl Zeiss; Dutch Ophthalmic Research Center International BV; Geuder AG.; and MedOne Surgical, Inc.
Vitreo Retinal Prefilled Silicone Oil Syringe Market Segment Insights
Type Segment Analysis
In terms of types/products, the market is divided into 1000 CST, 2000 CST, and others. The 1000 CST holds a major revenue share of the market and is projected to remain a dominant segment throughout the forecast period. The growth of this segment is attributed to its effectiveness, ease of use, and established use in vitreo retinal surgeries. 1000 CST is effective in treating retinal detachment and other vitreo-retinal disorders.
1000 CST silicone oil is widely used in vitreoretinal surgeries and has demonstrated good outcomes in clinical studies. Additionally, it is relatively easy to handle and has a lower risk of complications as compared to high-viscosity oils.
Application Segment Analysis
Based on application, the global vitreo retinal prefilled silicone oil syringe market is segmented into clinics, hospitals, and others. The hospitals segment is anticipated to account for a major share of the market during the forecast period, owing to advanced infrastructure and skilled professionals.
Hospitals are equipped with advanced surgical infrastructure, including operating rooms, specialized surgical instruments, and imaging technologies. This enables them to provide comprehensive vitreo retinal surgeries, including the use of pre-filled silicone oil syringes. For instance,
In March 2022, ZEISS received U.S. FDA clearance for QUATERA 700, a new phaco technology that provides surgeons with an efficient, digitally integrated cataract workflow. The device is specifically indicated for the emulsification and removal of cataracts and anterior segment vitrectomy.
On the basis of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America holds a significant share of the vitreo retinal pre-filled silicone oil syringe market. The growth of the market is attributed to the increasing prevalence of eye diseases and the rising geriatric population in the region. For instance,
In May 2022, an article published by BMC Ophthalmology stated that diabetic retinopathy (DR) is a potentially blinding complication of diabetes mellitus that affects approximately 28% of diabetics in the US each year. The article estimated that DR has a prevalence of around 44% among diabetic inpatients, and over half of these cases were previously undiagnosed.
Asia Pacific is anticipated to hold a major market share in the coming years, owing to the rising occurrence of retinal diseases and growing government spending for healthcare development in the region.
- Asia Pacific
- North America
- Latin America
- Middle East & Africa
- Alcon, Inc.
- Bausch & Lomb, Inc.
- Carl Zeiss
- Dutch Ophthalmic Research Center International BV
- Geuder AG.
- MedOne Surgical, Inc.
Major players competing in the global vitreo retinal prefilled silicone oil syringe market include Alcon, Inc.; Bausch & Lomb, Inc.; Carl Zeiss; Dutch Ophthalmic Research Center International BV; Geuder AG.; and MedOne Surgical, Inc.
Some of these companies are engaged in adopting several market strategies, such as collaborations, partnerships, mergers & acquisitions, R&D activities, and capacity expansion, to increase market share and global presence. For instance,
In July 2022, Moria, a company based in France, acquired Alchimia SRL, an Italy-based company that specializes in manufacturing devices for ophthalmic surgery and human tissue banking. This acquisition is expected to complement Moria's existing range of products for vitreoretinal surgery and keratoplasty.